Heliyon (Apr 2024)

Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination

  • Faustine Montmaneix-Engels,
  • Chloé Dimeglio,
  • Laeticia Staes,
  • Isabelle Da Silva,
  • Marion Porcheron,
  • Isabelle Jougla,
  • Fabrice Hérin,
  • Jacques Izopet

Journal volume & issue
Vol. 10, no. 7
p. e29116

Abstract

Read online

Our understanding of cellular immunity in response to COVID-19 infection or vaccination is limited because of less commonly used techniques. We investigated both the cellular and humoral immune responses before and after the administration of a third dose of the SARS-CoV-2 vaccine among a group of healthcare workers. Cellular immunity was evaluated using the VIDAS interferon-gamma (IFNγ) RUO test, which enables automated measurement of IFNγ levels after stimulating peripheral blood lymphocytes.Booster doses significantly enhanced both cellular and humoral immunity. Concerning cellular response, the booster dose increased the percentage of positive IFNγ release assay (IGRA) results but no difference in IFNγ release was found. The cellular response was not associated with protection against SARS-CoV-2 infection. Interestingly, vaccinated and infected healthcare workers exhibited the highest levels of anti-spike and neutralizing antibodies.In conclusion, the IGRA is a simple method for measuring cellular immune responses after vaccination. However, its usefulness as a complement to the study of humoral responses is yet to be demonstrated in future research.

Keywords